Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission

Blood (2010) 116 (7): 1132–1135.

https://doi.org/10.1182/blood-2009-07-234484

Published: 2010

Includes: Supplemental data

Journal Articles

Association of TET2 Alterations with NPM1 Mutations and Prognostic Value in De Novo Acute Myeloid Leukemia (AML).

Blood (2009) 114 (22): 163.

https://doi.org/10.1182/blood.V114.22.163.163

Published: 2009

Journal Articles

High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder

Claude Preudhomme, Aline Renneville, Violaine Bourdon, Nathalie Philippe, Catherine Roche-Lestienne, Nicolas Boissel, Nathalie Dhedin, Jean-Marie André, Pascale Cornillet-Lefebvre, André Baruchel, Marie-Joelle Mozziconacci, Hagay Sobol

Blood (2009) 113 (22): 5583–5587.

https://doi.org/10.1182/blood-2008-07-168260

Published: 2009

Includes: Supplemental data

Journal Articles

Incidence and Prognostic Impact of SNPs Regulating PU.1 Gene Expression in AML

Nicolas Boissel, Olivier Nibourel, Jean-Baptiste Micol, Nathalie Philippe, M. Crepin, Aline Renneville, Christine Terre, Sylvie Castaigne, Xavier Thomas, Herve Dombret, Claude Preudhomme

Blood (2008) 112 (11): 2949.

https://doi.org/10.1182/blood.V112.11.2949.2949

Published: 2008

Journal Articles

Which AML Subsets Benefit from Leukemic Cell Priming during Chemotherapy? Long-Term Analysis of the ALFA-9802 GM-CSF Study

Blood (2008) 112 (11): 765.

https://doi.org/10.1182/blood.V112.11.765.765

Published: 2008

Journal Articles

Incidence and Prognostic Impact of Gene Mutations in Older Patients with AML Treated in the ALFA-9801 Study.

Aline Renneville, Sylvie Castaigne, Sylvie Chevret, Laura Llopis, Nathalie Philippe, Olivier Nibourel, Sandrine Hayette, Jean-Michel Cayuela, Dina Naguib, Nathalie Gachard, Dominique Bories, Christian Bastard, Fatiha Merabet, Cécile Pautas, Christine Terré, Xavier Thomas, Hervé Dombret, Claude Preudhomme

Blood (2008) 112 (11): 1525.

https://doi.org/10.1182/blood.V112.11.1525.1525

Published: 2008

Journal Articles

RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL + leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance

Catherine Roche-Lestienne, Lauréline Deluche, Sélim Corm, Isabelle Tigaud, Sami Joha, Nathalie Philippe, Sandrine Geffroy, Jean-Luc Laï, Franck-Emmanuel Nicolini, Claude Preudhomme

Blood (2008) 111 (7): 3735–3741.

https://doi.org/10.1182/blood-2007-07-102533

Published: 2008

Includes: Supplemental data

Journal Articles

Trisomy 13, AML1 Mutations and M0 Subtype Are Remarkably Intricate Events in Acute Myeloid Leukemia (AML).

Olivier Nibourel, Christophe Roumier, Nathalie Philippe, Sabine Quief, Celine Villenet, Jean-Luc Laï, Nicole Dastugue, Isabelle Tigaud, John de Vos, Jean Soulier, Antonio Alberdi, Daniela Geromin, Eric Delabesse, Jean-Pierre Kerckaert, Claude Preudhomme

Blood (2007) 110 (11): 4250.

https://doi.org/10.1182/blood.V110.11.4250.4250

Published: 2007

Journal Articles

Evaluation of Minimal Residual Disease Based on NPM1 Mutations in AML with Intermediate Risk Cytogenetics: A Prospective Study of 36 Patients.

Aline Renneville, Florence Pasquier, Selim Corm, Nathalie Philippe, Charikleia Kelaidi, Catherine Roche-Lestienne, Virginie Eclache, Gerard Michel, Sylvie Castaigne, Pierre Fenaux, Claude Preudhomme

Blood (2007) 110 (11): 2847.

https://doi.org/10.1182/blood.V110.11.2847.2847

Published: 2007

Journal Articles

RUNX1 DNA-Binding Mutations and RUNX1-PRDM16 Cryptic Fusion in BCR/ABL+ Leukemias Are Frequently Associated with Secondary Trisomy 21 and May Contribute to Clonal Evolution and Imatinib Resistance.

Catherine Roche-Lestienne, PhD, Laureline Deluche, MD, Selim Corm, MD, Isabelle Tigaud, MD, Sami Joha, PhD, Nathalie Philippe, PhD, Sandrine Geffroy, PhD, Jean-Luc Lai, PhD, Franck Nicolini, MD, PhD, Claude Preudhomme, MD, PhD

Blood (2007) 110 (11): 2786.

https://doi.org/10.1182/blood.V110.11.2786.2786

Published: 2007

Journal Articles

Few Genes Expression Predicts Outcome in Adult Acute Myeloid Leukemia (AML) with Normal Karyotype.

Nicolas Boissel, Valeria Biggio, Aline Renneville, Nathalie Philippe, Jean-Michel Cayuela, Selim Corm, Emmanuel Raffoux, Stephane de Botton, Adrienne de Labarthe, Pierre Fenaux, Hervé Dombret, Claude Preudhomme

Blood (2005) 106 (11): 332.

https://doi.org/10.1182/blood.V106.11.332.332

Published: 2005

Journal Articles

NPM Mutations in Adult AML with Normal Karyotype: A Retrospective Study of the Acute Leukemia French Association (ALFA).

Nicolas Boissel, Aline Renneville, Valeria Biggio, Nathalie Philippe, Xavier Thomas, Jean-Michel Cayuela, Christine Terre, Isabelle Tigaud, Sylvie Castaigne, Emmanuel Raffoux, Stephane de Botton, Pierre Fenaux, Hervé Dombret, Claude Preudhomme

Blood (2005) 106 (11): 2359.

https://doi.org/10.1182/blood.V106.11.2359.2359

Published: 2005

Journal Articles

Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype

Nicolas Boissel, Aline Renneville, Valeria Biggio, Nathalie Philippe, Xavier Thomas, Jean-Michel Cayuela, Christine Terre, Isabelle Tigaud, Sylvie Castaigne, Emmanuel Raffoux, Stephane De Botton, Pierre Fenaux, Herve Dombret, Claude Preudhomme, for the Acute Leukemia French Association (ALFA)

Blood (2005) 106 (10): 3618–3620.

https://doi.org/10.1182/blood-2005-05-2174

Published: 2005

Journal Articles

Incidence and Prognosis of RTKs and RAS Mutations in CBF AML. A Retrospective Study of French Adult ALFA and Pediatric LAME Trials.

Nicolas Boissel, MD, Hugues Leroy, MD, Stephane De Botton, MD, Thierry Leblanc, MD, Nathalie Philippe, Andre Baruchel, MD, Olivier Hermine, MD, Herve Dombret, MD, Claude Preudhomme, MD

Blood (2004) 104 (11): 2022.

https://doi.org/10.1182/blood.V104.11.2022.2022

Published: 2004

Journal Articles

Molecular Characterization of the Idiopathic Hypereosinophilic Syndrome (HES) in 35 French Patients with Normal Conventional Cytogenetics.

Catherine Roche-Lestienne, PhD, Valerie Soenen-Cornu, MD, PhD, Jean-Emmanuel Kahn, MD, Jean-Luc Lai, PhD, Eric Hachulla, MD, Francois Drupt, MD, Anne-Laure Demarty, MD, Martine Gardembas, MD, Nathalie Philippe, Stephane Barette, MD, Christian Libersa, MD, PhD, Olivier Bletry, MD, PhD, Christian Rose, MD, PhD, Pierre Fenaux, MD, PhD, Lionel Prin, MD, PhD, Claude Preudhomme, MD, PhD

Blood (2004) 104 (11): 2442.

https://doi.org/10.1182/blood.V104.11.2442.2442

Published: 2004

Journal Articles

Poor Prognosis of Adult Acute Myeloid Leukemia (AML) with High Level of Evi1 and BAALC Transcript.

Valeria Biggio, Selim Corm, MD, Hugues Leroy, MD, Stephane De Botton, MD, Christophe Roumier, MD, Stephane Depil, MD, Nathalie Philippe, Jean-Luc Lai, MD, PHD, Francis Bauters, MD, PHD, Pierre Fenaux, MD, PHD, Claude Preudhomme, MD, PHD

Blood (2004) 104 (11): 2994.

https://doi.org/10.1182/blood.V104.11.2994.2994

Published: 2004

Journal Articles

Ras Pathway Activation in Childhood B-Lineage Acute Lymphoblastic Leukemia: Ras , Ptpn11 , and Flt3 Mutations.

Hélène Cavé, Sami Saba, Nathalie Philippe, Nathalie Grardel, Brigitte Nelken, Lucilia Norton, Alain Robert, Karima Yacouben, Etienne Vilmer, Yves Bertrand, Claude Preudhomme

Blood (2004) 104 (11): 166.

https://doi.org/10.1182/blood.V104.11.166.166

Published: 2004

Journal Articles

Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment

Catherine Roche-Lestienne, Valerie Soenen-Cornu, Nathalie Grardel-Duflos, Jean-Luc Laı̈, Nathalie Philippe, Thierry Facon, Pierre Fenaux, Claude Preudhomme

Blood (2002) 100 (3): 1014–1018.

https://doi.org/10.1182/blood.V100.3.1014

Published: 2002

NARROW

Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission

Association of TET2 Alterations with NPM1 Mutations and Prognostic Value in De Novo Acute Myeloid Leukemia (AML).

High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder

Incidence and Prognostic Impact of SNPs Regulating PU.1 Gene Expression in AML

Which AML Subsets Benefit from Leukemic Cell Priming during Chemotherapy? Long-Term Analysis of the ALFA-9802 GM-CSF Study

Incidence and Prognostic Impact of Gene Mutations in Older Patients with AML Treated in the ALFA-9801 Study.

RUNX1 DNA-binding mutations and RUNX1-PRDM16 cryptic fusions in BCR-ABL + leukemias are frequently associated with secondary trisomy 21 and may contribute to clonal evolution and imatinib resistance

Trisomy 13, AML1 Mutations and M0 Subtype Are Remarkably Intricate Events in Acute Myeloid Leukemia (AML).

Evaluation of Minimal Residual Disease Based on NPM1 Mutations in AML with Intermediate Risk Cytogenetics: A Prospective Study of 36 Patients.

RUNX1 DNA-Binding Mutations and RUNX1-PRDM16 Cryptic Fusion in BCR/ABL+ Leukemias Are Frequently Associated with Secondary Trisomy 21 and May Contribute to Clonal Evolution and Imatinib Resistance.

Few Genes Expression Predicts Outcome in Adult Acute Myeloid Leukemia (AML) with Normal Karyotype.

NPM Mutations in Adult AML with Normal Karyotype: A Retrospective Study of the Acute Leukemia French Association (ALFA).

Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype

Incidence and Prognosis of RTKs and RAS Mutations in CBF AML. A Retrospective Study of French Adult ALFA and Pediatric LAME Trials.

Molecular Characterization of the Idiopathic Hypereosinophilic Syndrome (HES) in 35 French Patients with Normal Conventional Cytogenetics.

Poor Prognosis of Adult Acute Myeloid Leukemia (AML) with High Level of Evi1 and BAALC Transcript.

Ras Pathway Activation in Childhood B-Lineage Acute Lymphoblastic Leukemia: Ras , Ptpn11 , and Flt3 Mutations.

Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to STI571, and they can pre-exist to the onset of treatment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only